AB42. Metabolic evaluation for urinary stone disease
AB42. Metabolic evaluation for urinary stone disease
Podium Lecture
AB42. Metabolic evaluation for urinary stone disease
Thomas Chi
Department of Urology, School of Medicine, University of California, San Francisco, CA 94143, USA.
Abstract: Urinary stone disease affects up to 15% of people globally. The etiology of stones may range from nutrition to behavior to genetics. After a first time occurence of a sympomatic stone, up to 50% of patients may experience another stone within 5 years. Thus, metabolic evaluation for the prevention of stone recurrence can play a major role in reducing the morbidity associated with urinary stones. This session will focus on the means by which we evaluate our nephrolithiasis patients and counsel them based on these results.
Keywords: Metabolic evaluation; urinary stone disease; nephrolithiasis patients
doi: 10.3978/j.issn.2223-4683.2014.s042
Cite this article as: Chi T. Metabolic evaluation for urinary stone disease. Transl Androl Urol 2014;3(S1):AB42. doi: 10.3978/j.issn.2223-4683.2014.s042